Commonwealth Equity Services, LLC Trevena Inc Transaction History

Commonwealth Equity Services, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.2 - $0.5 $62 - $156	-313 Reduced 2.44%	12,508 $5,000
Q1 2022 May 04, 2022	SELL	$0.41 - $0.63 $410 - $630	-1,000 Reduced 7.24%	12,821 $7,000
Q4 2021 Jan 31, 2022	SELL	$0.57 - $1.29 $170 - $387	-300 Reduced 2.12%	13,821 $8,000
Q3 2021 Oct 29, 2021	SELL	$1.11 - $1.7 $444 - $680	-400 Reduced 2.75%	14,121 $17,000
Q2 2021 Aug 11, 2021	SELL	$1.46 - $2.25 $3,682 - $5,674	-2,522 Reduced 14.8%	14,521 $24,000
Q1 2021 May 04, 2021	BUY	$1.77 - $2.93 $902 - $1,494	510 Added 3.08%	17,043 $30,000
Q3 2020 Nov 05, 2020	BUY	$1.53 - $3.13 $8,124 - $16,620	5,310 Added 47.31%	16,533 $49,000
Q2 2020 Aug 12, 2020	BUY	$0.48 - $1.75 $5,387 - $19,640	11,223 New	11,223 $16,000
Q4 2018 Feb 11, 2019	SELL	$0.39 - $3.47 $4,238 - $37,711	-10,868 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$1.39 - $2.25 $15,106 - $24,453	10,868 New	10,868 $23,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.